References
Study flowchart.Changes in 24-h urinary sodium excretion over time, with adjustments made for baseline SBP and DBP, as well as the use of diuretics, adrenergic blockers, beta-blockers, ACE inhibitors, vasodilators, calcium channel blockers, AT1 receptor antagonists of angiotensin II. The reduction in urinary sodium excretion over time was statistically significant for within-group comparisons (Baseline participants’ characteristics [n (%) or mean ± SD].ACE, angiotensin-converting enzyme; AT1R, Angiotensin II Receptor Type-1. Laboratory reference values: Total cholesterol <190 mg/dL; LDL-C <130 mg/dL; HDL-C >40 mg/dL; Triglycerides <150 mg/dL; Fasting glucose <100 mg/dL; Creatinine 0.50–1.20 women and 0.60–1.30 mg/dL men; Potassium 3.5–5.1 mEq/L.Patient barriers to low-sodium dietary adherence, attitude, and benefit scores [mean ± SD].* Higher score indicates a more positive attitude toward a low-sodium diet. ** Higher score indicates greater difficulty in adhering to the low-sodium diet.Delta differences for 24-h sodium estimated, blood pressure, and weight, index between groups.* The number of participants analyzed is different between variables due to missing data. ** Intervention delta minus control delta. *** General linear model (GLM) adjusted for respective baseline values. SBP, systolic blood pressure; DBP, diastolic blood pressure.